StockData
Artivion, Inc. logo

Artivion, Inc. (AORT) shareholders

AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.27−0.20 (-1.08%)

Close on Nov 17, 2026Market cap $890.78MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
94.9%
46M of 49M shares
Institutional holders
206
37 new, 66 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 48 sales
Net sold $15.06M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.7,159,27914.70%13G (passive) amendmentSep 30, 2026
Nomura Asset Management International Inc.
Joint filing with Nomura Investment Management Business Trust (6.50%)
3,184,9746.50%13G (passive) amendmentJun 30, 2026
Nomura Investment Management Business Trust
Joint filing with Nomura Asset Management International Inc. (5.50%)
2,613,4715.50%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of AORTValueChange% of portfolio
BlackRock, Inc.6,674,01713.69%$149.97M+199,1630.00%
Nomura Asset Management International Inc.3,184,9746.53%$71.57M+728,8280.11%
Morgan Stanley2,557,9615.25%$57.48M+288,6670.00%
Juniper Investment Company, LLC2,019,8854.14%$45.39M+830,74912.02%
Vanguard Capital Management LLC2,004,6194.11%$45.04M+52,6110.00%
FMR LLC1,963,4714.03%$44.12M−619,9560.00%
State Street Corp1,858,0513.81%$41.75M+175,7780.00%
Ophir Asset Management Pty Ltd1,800,0083.69%$40.45M+849,1583.33%
Perceptive Advisors LLC1,737,2903.56%$39.04M+100,0000.59%
Conestoga Capital Advisors, LLC1,623,7003.33%$36.48M+448,2900.79%
Wellington Management Group Llp1,260,2792.58%$28.32M+103,5920.00%
Geode Capital Management, LLC1,114,2972.29%$25.04M−18,2060.00%
Silvercrest Asset Management Group LLC1,024,0912.10%$23.01M+363,1500.15%
Vanguard Portfolio Management LLC988,2192.03%$22.21M−49,2260.00%
Dimensional Fund Advisors LP947,9411.94%$21.30M−79,6340.00%
Citadel Advisors LLC827,5941.70%$18.60M+756,7250.00%
GW&K Investment Management, LLC794,4781.63%$17.85M+55,7750.14%
First Eagle Investment Management, LLC693,1461.42%$15.57M+381,5450.01%
Royce & Associates LP639,2821.31%$14.36M+214,0000.12%
Yarger Wealth Strategies, LLC634,2231.30%$15.28M–5.49%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202620646M94.9%37 / 8458 / 669M7M
Q1 202623944M91.1%37 / 9566 / 389M4M
Q4 202524343M88.5%40 / 8979 / 157M6M
Q3 202521942M87.1%48 / 7663 / 165M4M
Q2 202518842M85.7%29 / 7157 / 244M3M
Q1 202518441M84.3%33 / 5558 / 215M2M
Q4 202417438M78.3%23 / 5559 / 233M1M
Q3 202417436M74.3%29 / 6348 / 179M2M
Q2 202416336M72.9%32 / 4756 / 192M6M
Q1 202415140M81.7%25 / 4052 / 155M2M
Q4 202314137M74.9%14 / 4354 / 154M1M
Q3 202314234M69.8%20 / 3951 / 41M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

234 funds held AORT in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of AORTValue% of fundAs of
iShares Core S&P Small-Cap ETF2,574,1835.28%$57.84M0.05%Jun 30, 2026
Nomura Small Cap Core Fund1,737,1063.56%$38.55M0.70%May 29, 2026
Vanguard Total Stock Market Index Fund1,463,3403.00%$32.88M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,186,6842.43%$26.66M0.03%Jun 30, 2026
Conestoga Small Cap Fund962,6201.97%$21.63M1.06%Jun 30, 2026
Fidelity Small Cap Value Fund610,5731.25%$16.38M0.30%Jul 31, 2026
Nomura Small Cap Growth Fund547,6051.12%$12.30M1.05%Jun 30, 2026
Fidelity Small Cap Growth Fund532,5771.09%$14.29M0.16%Jul 31, 2026
Fidelity Stock Selector Small Cap Fund510,6131.05%$13.70M0.19%Jul 31, 2026
Fidelity Small Cap Index Fund498,9981.02%$13.39M0.04%Jul 31, 2026
Vanguard Extended Market Index Fund495,4401.02%$11.13M0.01%Jun 30, 2026
iShares Russell 2000 Growth ETF429,4400.88%$9.65M0.06%Jun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF390,5080.80%$8.77M0.05%Jun 30, 2026
iShares S&P Small-Cap 600 Growth ETF382,7390.79%$8.60M0.10%Jun 30, 2026
First Eagle Small Cap Opportunity Fund322,5500.66%$8.65M0.30%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Andrew M. GreenSVP, Regulatory and Quality40,1600.08%Sep 11, 2026
James P. MackinPresident & CEO877,2751.80%Aug 20, 2026
Lance A. BerryEVP, COO, CFO & Treasurer210,1120.43%Aug 17, 2026
Jean F. HollowaySVP, General Counsel184,1180.38%Aug 12, 2026
Amy HortonVP, Chief Accounting Officer139,0880.29%Mar 4, 2026
John E. DavisChief Commercial Officer230,7940.47%Mar 4, 2026
Marshall S. StantonSVP, Clinical & MD Affair60,0970.12%Mar 4, 2026
Anthony B. SemedoDirector47,5600.10%Jun 4, 2026
James BullockDirector76,2230.16%May 20, 2026
Jeffrey H. BurbankDirector61,3720.13%May 20, 2026
Marna P. BorgstromDirector56,6640.12%May 20, 2026
Elizabeth A. HoffDirector34,7650.07%May 20, 2026
Daniel J. BevevinoDirector157,6370.32%May 20, 2026
Thomas F. AckermanDirector157,4720.32%May 20, 2026
Jon W. SalvesonDirector137,4160.28%May 20, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Andrew M. Green
SVP, Regulatory and Quality
Sep 10, 2026Sale−11,480$24.97$286.66K40,160
Andrew M. Green
SVP, Regulatory and Quality
Sep 3, 2026Sale−1,493$26.02$38.85K51,640
Andrew M. Green
SVP, Regulatory and Quality
Sep 2, 2026Sale−6,510$27.27$177.53K53,133
James P. Mackin
President & CEO
Aug 19, 2026Sale−70,000$28.96$2.03M877,275
Andrew M. Green
SVP, Regulatory and Quality
Aug 14, 2026Sale−616$28.55$17.59K59,643
Lance A. Berry
EVP, COO, CFO & Treasurer
Aug 14, 2026Sale−715$28.55$20.41K210,112
Jean F. Holloway
SVP, General Counsel
Aug 12, 2026Sale−977$28.49$27.83K184,118
Andrew M. Green
SVP, Regulatory and Quality
Jun 11, 2026Option exercise+30,000$11.03$330.90K90,259
Andrew M. Green
SVP, Regulatory and Quality
Jun 11, 2026Sale(10b5-1 plan)−14,001$20.71$289.96K60,259
Andrew M. Green
SVP, Regulatory and Quality
Jun 11, 2026Option exercise+14,001$18.44$258.18K74,260
Andrew M. Green
SVP, Regulatory and Quality
Jun 11, 2026Sale(10b5-1 plan)−30,000$20.69$620.70K60,259
Anthony B. Semedo
Director
Jun 2, 2026Other+6,325––6,325
Anthony B. Semedo
Director
Jun 2, 2026Other−6,325––40,635
Jeffrey H. Burbank
Director
May 18, 2026Award+7,576––61,372
Daniel J. Bevevino
Director
May 18, 2026Award+7,576––157,637
Thomas F. Ackerman
Director
May 18, 2026Award+7,576––157,472
Jon W. Salveson
Director
May 18, 2026Award+7,576––137,416
Marna P. Borgstrom
Director
May 18, 2026Award+7,576––56,664
Elizabeth A. Hoff
Director
May 18, 2026Award+7,576––34,765
James Bullock
Director
May 18, 2026Award+7,576––76,223
Anthony B. Semedo
Director
May 18, 2026Award+7,576––46,960
Marna P. Borgstrom
Director
May 14, 2026Award+7,850––56,938
Jean F. Holloway
SVP, General Counsel
Mar 4, 2026Sale−8,962$38.00$340.56K185,095
Marshall S. Stanton
SVP, Clinical & MD Affair
Mar 3, 2026Sale−2,149$37.78$81.19K60,097
James P. Mackin
President & CEO
Mar 3, 2026Sale−17,887$37.78$675.77K947,275
Lance A. Berry
EVP, COO, CFO & Treasurer
Mar 3, 2026Sale−6,316$37.78$238.62K210,827
Jean F. Holloway
SVP, General Counsel
Mar 3, 2026Sale−3,843$37.78$145.19K194,057
Amy Horton
VP, Chief Accounting Officer
Mar 3, 2026Sale−901$37.78$34.04K139,088
John E. Davis
Chief Commercial Officer
Mar 3, 2026Sale−4,573$37.78$172.77K230,794
Marshall S. Stanton
SVP, Clinical & MD Affair
Mar 2, 2026Award+21,838––62,246
James P. Mackin
President & CEO
Mar 2, 2026Award+116,948––965,162
Lance A. Berry
EVP, COO, CFO & Treasurer
Mar 2, 2026Award+40,874––217,143
Jean F. Holloway
SVP, General Counsel
Mar 2, 2026Award+27,795––197,900
Amy Horton
VP, Chief Accounting Officer
Mar 2, 2026Award+7,475––139,989
John E. Davis
Chief Commercial Officer
Mar 2, 2026Award+28,845––235,367
Marshall S. Stanton
SVP, Clinical & MD Affair
Mar 2, 2026Sale−1,513$38.02$57.52K40,408
James P. Mackin
President & CEO
Mar 2, 2026Sale−14,911$38.02$566.92K848,214
Lance A. Berry
EVP, COO, CFO & Treasurer
Mar 2, 2026Sale−5,178$38.02$196.87K176,269
Amy Horton
VP, Chief Accounting Officer
Mar 2, 2026Sale−641$38.02$24.37K132,514
John E. Davis
Chief Commercial Officer
Mar 2, 2026Sale−2,784$38.02$105.85K206,522
Jean F. Holloway
SVP, General Counsel
Mar 2, 2026Sale−2,183$38.02$83.00K170,105
Marshall S. Stanton
SVP, Clinical & MD Affair
Feb 24, 2026Sale−1,259$35.69$44.93K41,921
John E. Davis
Chief Commercial Officer
Feb 24, 2026Award+20,438––209,306
John E. Davis
Chief Commercial Officer
Feb 24, 2026Sale−2,075$35.69$74.06K188,868
Amy Horton
VP, Chief Accounting Officer
Feb 24, 2026Award+5,658––133,155
Amy Horton
VP, Chief Accounting Officer
Feb 24, 2026Sale−830$35.69$29.62K127,497
Jean F. Holloway
SVP, General Counsel
Feb 24, 2026Sale−1,668$35.69$59.53K152,203
Jean F. Holloway
SVP, General Counsel
Feb 24, 2026Award+20,085––172,288
Lance A. Berry
EVP, COO, CFO & Treasurer
Feb 24, 2026Award+37,482––181,447
Lance A. Berry
EVP, COO, CFO & Treasurer
Feb 24, 2026Sale−4,485$35.69$160.07K143,965
James P. Mackin
President & CEO
Feb 24, 2026Sale−13,936$35.69$497.38K766,095
James P. Mackin
President & CEO
Feb 24, 2026Award+97,030––863,125
Marshall S. Stanton
SVP, Clinical & MD Affair
Feb 23, 2026Sale−2,423$37.59$91.08K43,180
John E. Davis
Chief Commercial Officer
Feb 23, 2026Sale−3,773$37.59$141.83K190,943
Amy Horton
VP, Chief Accounting Officer
Feb 23, 2026Sale−1,731$37.59$65.07K128,327
Jean F. Holloway
SVP, General Counsel
Feb 23, 2026Sale−3,079$37.59$115.74K153,871
Lance A. Berry
EVP, COO, CFO & Treasurer
Feb 23, 2026Sale−4,981$37.59$187.24K148,450
James P. Mackin
President & CEO
Feb 23, 2026Sale−20,962$37.59$787.96K780,031
Marshall S. Stanton
SVP, Clinical & MD Affair
Dec 31, 2025Award+316$26.14$8.26K45,603
Jean F. Holloway
SVP, General Counsel
Dec 31, 2025Award+228$26.14$5.96K156,950

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
7.68%
3M shares short
Days to cover
7.2
At 0M shares a day
Change since last report
-8.6%
From 4M shares
Short volume, 20 days
55.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Artivion's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,539 shares on Aug 28, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Andrew M. Green
Officer
Sep 10, 202611,480$286.66KSep 10, 2026Restricted Stock Vesting
Andrew M. Green
Officer
Sep 3, 20261,493$38.84KSep 3, 2026Restricted Stock Vesting
Andrew M. Green
Officer
Sep 2, 20266,510$177.50KSep 2, 2026Restricted Stock Vesting
Marshall S. Stanton
Officer
Aug 27, 20267,400$198.69KAug 27, 2026ESPP Purchase
James P. Mackin
Officer
Aug 19, 202670,000$2.05MAug 19, 2026Payment for Services Rendered
Lance A. Berry
Officer
Aug 14, 2026715$20.41KAug 14, 2026Restricted Stock Vesting
Andrew M. Green
Officer
Aug 14, 2026616$17.59KAug 14, 2026Restricted Stock Vesting
Andrew M. Green
Officer
Jun 11, 202644,001$910.75KJun 11, 2026Stock Option Exercise
Jean F. Holloway
Officer
Mar 4, 20268,962$340.56KMar 4, 2026Performance Shares
Jean F. Holloway
Officer
Mar 3, 20263,843$145.17KMar 3, 2026Restricted Stock Vesting
John E. Davis
Officer
Mar 3, 20264,573$172.75KMar 3, 2026Restricted Stock Vesting
Lance A. Berry
Officer
Mar 3, 20266,316$238.59KMar 3, 2026Restricted Stock Vesting
Marshall S. Stanton
Officer
Mar 3, 20262,149$81.18KMar 3, 2026Restricted Stock Vesting
James P. Mackin
Officer, Director
Mar 3, 202617,887$675.69KMar 3, 2026Restricted Stock Vesting
Amy Horton
Officer
Mar 3, 2026901$34.04KMar 3, 2026Restricted Stock Vesting

Congress trades

13 trades in Artivion reported by 2 members of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
BoughtAug 20, 2026$1K–15KSep 10, 2026
Gilbert Cisneros
CA31
BoughtJul 16, 2026$1K–15KSep 4, 2026
50 days late
Gilbert Cisneros
CA31
Sold (part)Oct 9, 2025$1K–15KNov 18, 2025
Josh Gottheimer
NJ05 · joint account
BoughtJul 14, 2023$1K–15KAug 21, 2023
Josh Gottheimer
NJ05 · joint account
Sold (part)Jun 13, 2023$1K–15KJul 11, 2023
Josh Gottheimer
NJ05 · joint account
BoughtOct 16, 2020$1K–15KNov 5, 2020
Josh Gottheimer
NJ05 · joint account
SoldSep 15, 2020$1K–15KOct 13, 2020
Gilbert Cisneros
CA31
BoughtAug 12, 2020$1K–15KSep 14, 2020
Gilbert Cisneros
CA31
BoughtJul 17, 2020$1K–15KAug 19, 2020
Gilbert Cisneros
CA31
BoughtJun 25, 2020$1K–15KJul 17, 2020
Gilbert Cisneros
CA31
BoughtMay 11, 2020$1K–15KJun 16, 2020
Gilbert Cisneros
CA31
BoughtJan 17, 2020$1K–15KFeb 18, 2020
Josh Gottheimer
NJ05 · joint account
BoughtJan 14, 2020$1K–15KFeb 10, 2020

See a number that looks wrong?